Monumental Financial Group Inc. Amgen Inc Transaction History

Monumental Financial Group Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$230.71 - $256.74 $7,382 - $8,215	-32 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$219.27 - $242.57 $7,016 - $7,762	32 New	32 $8,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $583,716 - $647,590	-2,499 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $554,553 - $646,241	2,499 New	2,499 $622,000

2,933

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Monumental Financial Group Inc., based on Form 13F filings with the SEC.

Stay updated on Monumental Financial Group Inc. with notifications on news.